Suppr超能文献

治疗腮腺良性多形性腺瘤的复发

Treating recurrence of parotid benign pleomorphic adenomas.

作者信息

Yugueros P, Goellner J R, Petty P M, Woods J E

机构信息

Division of Plastic & Reconstructive Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.

出版信息

Ann Plast Surg. 1998 Jun;40(6):573-6. doi: 10.1097/00000637-199806000-00001.

Abstract

Treatment for recurrence after surgical removal of parotid benign pleomorphic adenoma (PBPA) has not been well defined and is often followed by further recurrence. Surgery is overwhelmingly the most common approach. The risk of facial nerve injury is greater at reoperation since the nerve is less well defined. The value of radiation therapy (RT) has not been determined and incurs with it the risk of possible late occurrence of malignancy or nerve damage. The charts of patients with recurrent PBPA treated consecutively by a single surgeon from 1965 to 1993 were reviewed. All patients had a histopathologically verified diagnosis of PBPA both at the time of primary and subsequent surgeries. Follow-up was obtained from clinical charts and correspondence communication. Recurrence curves were generated using the Kaplan-Meier method. Thirty-nine patients with recurrent PBPA (36 referred and 3 treated primarily at Mayo) were evaluated. The patients were classified according to the type of surgery: 14 patients had previously undergone some form of parotidectomy or had only resection of the tumor for recurrence, and 25 patients underwent parotidectomy since this had not been performed primarily. The mean age in the two groups was 49 and 50 years respectively. The mean follow-up was 10 years after the recurrence treatment. The mean time between initial resection and recurrence in the two groups was 14 and 15 years. The mean time between the recurrence treatment and a second recurrence was 7.5 years. Nine patients had RT in addition to the local resection. Of this group 3 patients (33%) developed another recurrence. Five patients had local resection only, and of this group 1 patient (20%) developed another recurrence. Of the group that had superficial parotidectomy, 3 patients had additional RT and one of these patients (33%) developed another recurrence. Twenty-two patients had superficial parotidectomy only, and of this group 3 patients (14%) developed another recurrence. Only 2 of the 39 patients had complications. One patient developed Frey's syndrome after superficial parotidectomy and 1 patient developed facial paralysis after RT. As in other series, the number of patients is inadequate to allow for firm conclusions. However, it appears that when previous parotidectomy has been performed, simple excision with a margin of surrounding tissue would seem appropriate. Parotidectomy should be carried out if not performed previously. In simple excision after previous parotidectomy, there is a greater risk to the facial nerve because of difficulty in distinguishing the facial nerve from surrounding scar tissue. Our preference is to use general anesthesia so that branches of the nerve are not paralyzed and stimulation of the nerve aids in safe dissection. The value of RT is still indeterminate.

摘要

腮腺良性多形性腺瘤(PBPA)手术切除后复发的治疗方法尚未明确界定,且常常会再次复发。手术是最为常见的治疗方法。再次手术时面神经损伤风险更大,因为神经界限不如之前清晰。放射治疗(RT)的价值尚未确定,且存在后期发生恶性肿瘤或神经损伤的风险。回顾了1965年至1993年由一位外科医生连续治疗的复发性PBPA患者的病历。所有患者在初次手术及后续手术时均经组织病理学确诊为PBPA。通过临床病历和通信获得随访信息。采用Kaplan-Meier方法生成复发曲线。对39例复发性PBPA患者(36例为转诊患者,3例为梅奥诊所初诊患者)进行了评估。根据手术类型对患者进行分类:14例患者此前曾接受某种形式的腮腺切除术,或仅因复发而切除肿瘤,25例患者因初次未行腮腺切除术而接受了腮腺切除术。两组患者的平均年龄分别为49岁和50岁。复发治疗后的平均随访时间为10年。两组患者初次切除与复发之间的平均时间为14年和15年。复发治疗与再次复发之间的平均时间为7.5年。9例患者在局部切除的基础上还接受了RT。该组中有3例患者(33%)再次复发。5例患者仅接受了局部切除,该组中有1例患者(20%)再次复发。在接受浅叶腮腺切除术的患者组中,3例患者还接受了RT,其中1例患者(33%)再次复发。22例患者仅接受了浅叶腮腺切除术,该组中有3例患者(14%)再次复发。39例患者中只有2例出现并发症。1例患者在浅叶腮腺切除术后出现了味觉出汗综合征,1例患者在接受RT后出现了面瘫。与其他系列研究一样,患者数量不足以得出确凿结论。然而,似乎如果之前已经进行过腮腺切除术,简单切除周围组织边缘似乎是合适的。如果之前未进行腮腺切除术,则应进行腮腺切除术。在之前进行过腮腺切除术后进行简单切除时,由于难以将面神经与周围瘢痕组织区分开来,面神经面临的风险更大。我们倾向于使用全身麻醉,这样神经分支不会麻痹,对神经的刺激有助于安全解剖。RT的价值仍然不确定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验